GNAS encodes a G protein alpha stimulatory subunit and is of interest given activating mutations have been proposed to mediate resistance to EGFR inhibitors and activate Wnt/β-catenin signaling pathways in gastric adenocarcinomas (22, 23). This evidence concerns the gene GNAS and gastric adenocarcinoma.